What originally attracted me:
I was looking for a way to find some exposure to tech IPOs in January 2020 that was less volatile or overpriced than the frothy offerings that have been the
Hercules Capital: 8% Yield With An Adept Response To The Pandemic
Summary
- Hercules offers 8% yield with exposure to tech and life sciences funding.
- Hot IPO and special events market has been a boon.
- The pandemic strategy of building upon existing relationships is paying off.
- Hercules Advisor represents expansion opportunity.
I am an investor with an unrelated PhD and no experience in finance. I have been investing for 14 years and keep up with due diligence for the news that affects my own portfolio. I have some opinions that I would like to share with others and this seems to be a fairly reasonable place to do so. I tend to follow a dividend and value approach in my main portfolio, but also have interest in speculative small caps for a smaller portfolio. Free: Readers can get an e-mail once a day from Seeking Alpha that lists all newly published articles of ALL the authors they follow in a single e-mail. To get these updates: - a - Click "Alerts" along the top menu tab (just left of the green PRO tab) - b - Scroll all the way down, and check the box for "author alerts" (2nd box from the bottom) - c - Then you'll be notified by Seeking Alpha once per day of new articles by all authors you follow (in a single e-mail)
Analyst’s Disclosure:I am/we are long HTGC. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.